Moderate evidence
More
Thyroid slide reviews 40% to 65% faster with AI, but more false positives, study found
Study title: Artificial intelligence-assisted digital thyroid FNA cytology: Improved agreement and sensitivity for higher-risk Bethesda categories with enhanced screening efficiency
- Evidence type
- Controlled or validated comparison
- Sample
- n = 100
- Sources
- 1 sourcePeer-reviewed
- Published
- 1 min read
- Truvace record
- TRV-2026-1235cite or check it
Study title: Artificial intelligence-assisted digital thyroid FNA cytology: Improved agreement and sensitivity for higher-risk Bethesda categories with enhanced screening efficiency
In a 100-slide archival study, two cytopathologists and one cytologist reviewed thyroid fine-needle aspiration cases using microscopy and two AI-assisted whole-slide imaging modes powered by the AIxTHY algorithm. By the October 2026 publication date, the authors reported improved agreement with expert consensus for higher-risk Bethesda categories and a 40% to 65% reduction in review time.
Read the study abstract
Background Accurate cytologic classification of thyroid nodules is essential for clinical management, but interobserver variability and indeterminate interpretations remain persistent challenges. The clinical feasibility of AIxTHY, a disease-specific deep-learning algorithm integrated into a digital cytology platform, was evaluated for assisting thyroid fine-needle aspiration (FNA) diagnosis using whole-slide imaging (WSI). Methods Two cytopathologists and one cytologist independently reviewed 100 archival ThinP…

64Gain side
How the two sides scoreGain scores higher
56Problem side
The gain
In a 100-slide test with three reviewers, AI assistance raised sensitivity for higher-risk thyroid cases from 60% to 78-79% and cut slide review time by 40% to 65% compared with microscopy.
The problem
In a 100-slide test with three reviewers, AI assistance lowered specificity because it produced more false positives, particularly in indeterminate thyroid cases.
A fixed formula sets both scores from the evidence and its sources. Reader votes don’t move them.
What the scores mean
G is the gain side, out of 100. It goes up when the gain is specific, when it measurably helped people and when the sources behind it are strong.
P is the problem side, out of 100. It goes up when the problem is specific, when it measurably hurt people and when the sources behind it are strong.
In brief
The findings matter because thyroid nodule triage depends on accurate Bethesda classification, where interobserver variability and indeterminate results affect management. While sensitivity and workflow efficiency improved, specificity fell due to false positives in indeterminate lesions, leaving uncertainty about clinical impact, generalizability beyond the small reviewer group, and performance on prospective cases.
Main points
- Study evaluated AIxTHY, a disease-specific deep-learning algorithm integrated into a digital cytology platform using whole-slide imaging.
- Two cytopathologists and one cytologist independently reviewed 100 archival ThinPrep FNA slides across microscopy, AI-assisted single-layer WSI, and AI-assisted seven-layer Z-stack WSI with 2-week washout intervals.
- For binary risk stratification TBS III+ vs TBS II, sensitivity rose from 60% to 78% to 79% and accuracy from 61% to approximately 71% with AI assistance.
- Review time fell by 40% to 65% across diagnostic categories with AI-assisted modalities.
The full story
Researchers tested AIxTHY on 100 archival ThinPrep thyroid FNA slides, comparing microscopy to AI-assisted single-layer and seven-layer Z-stack whole-slide imaging. Three reviewers assigned Bethesda categories with washout intervals, using expert cytologic consensus as ground truth and recording review times.
AI-assisted modalities showed higher agreement for TBS III+ categories and less downgrading versus microscopy, with sensitivity gains from 60% to 78-79% for TBS III+ versus TBS II. The trade-off was lower specificity from false positives in indeterminate cases, and authors noted feasibility as an adjunct pending specificity improvements.
What this doesn’t fix
Specificity decreased with AI assistance due to false positives in indeterminate lesions, indicating need for further refinement before routine clinical use.
Sources
1 on file- Cancer Cytopathologydoi:10.1002/cncy.70149
Talk it over
AI assistance raised sensitivity for higher-risk cases from 60% to 78-79% and cut review time by 40% to 65%, but it produced more false positives in indeterminate cases. How do you weigh the speed and sensitivity against the lost specificity?
Thyroid slide reviews 40% to 65% faster with AI, but more false positives, study foundhttps://truvace.com/item/artificial-intelligence-assisted-digital-thyroid-fna-cytology-improved-agreement
AI assistance raised sensitivity for higher-risk cases from 60% to 78-79% and cut review time by 40% to 65%, but it produced more false positives in indeterminate cases. How do you weigh the speed and sensitivity against the lost specificity?
Answer in the threadTwo cytopathologists and one cytologist reviewed 100 archival slides against an expert consensus. How far would results from three reviewers working on old slides carry over to a busy lab, and what would settle it?
Answer in the threadIf you were one of the three reviewers looking at an indeterminate slide that the AI flagged, how would you decide whether to trust the flag or your own reading from the microscope?
Answer in the thread
If you have more time
The authors describe AIxTHY as a possible adjunct pending better specificity. What would you want to see in a prospective study of new cases before a hospital used it routinely?
Answer in the threadThe reviewers worked through microscopy, single-layer imaging and seven-layer Z-stack imaging with 2-week washout intervals. How might that design have affected the time and accuracy results, and what would you ask the researchers about it?
Answer in the thread
ace
What readers say